Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) reported a drop of 36.15% in 2020 revenues to CAD 14.261 million. The company posted a loss of CAD 13.175 million in 2020. Its SG&A and R&D expenses declined to CAD 10.983 million and CAD 1.56 million in 2020....
